findmyKOL

Robert Ike, MD

Basic profile

University of Michigan

ORCIDNPI
RegionAnn Arbor, MI · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding1997–1997Why? →

Robert Ike is a Rheumatology/Immunology physician affiliated with University of Michigan. OpenAlex indexes 76 publications with 5,900 citations (h-index 23).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
76publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,900citations

Total citations across indexed works.

23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1997–1997

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1500 E Medical Center Dr
Ann Arbor, MI 481095000

Telephone

734-936-4000

Registry record last updated 13 May 2019.

View the NPPES registry record

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    41.3%
    Folate Analog Metabolic Inhibitor24.3%
    Methotrexate100%
    Part D18 patients
    Antirheumatic Agent11%
    Leflunomide100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    28.9%
    Corticosteroid28.9%
    Prednisone100%
    Part D27 patients
  • Musculoskeletal

    18.3%
    Nonsteroidal Anti-inflammatory Drug11%
    Diclofenac Sodium54%Indomethacin46%
    Part D<11 patients
    Muscle Relaxant7.3%
    Cyclobenzaprine Hcl100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19971997 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”